- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GL Pharm Tech Corp (204840)
Assess today's live GL Pharm Tech Corp (204840) share price, performance and insights using our live KOSDAQ: 204840 stock exchange data.
Analyse the historical data and GL Pharm Tech Corp share price performance charts on this page. Our technical summary section provides analysis on GL Pharm Tech share price buy/sell indicators using real-time data (or discuss the GL Pharm Tech (204840) stock price today with other investors in the GL Pharm Tech KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ 204840 share price (ISIN: KR7204840003) to enhance your trading decisions with our free investment tools and resources.
What Is the GL Pharm Tech Corp Share Price Today?
The GL Pharm Tech share price today is 1,045.
What Is the Stock Symbol for GL Pharm Tech Corp
The stock symbol (or 'ticker') for GL Pharm Tech Corp is "204840."
What Stock Exchange Does GL Pharm Tech Corp Trade On?
GL Pharm Tech Corp is listed and trades on the KOSDAQ stock exchange.
Is GL Pharm Tech Corp a Good Stock to Buy?
Determining whether GL Pharm Tech Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and GL Pharm Tech Corp share price performance charts on this page. Our technical summary section provides analysis on GL Pharm Tech share price buy/sell indicators using real-time data (or discuss the GL Pharm Tech (204840) stock price today with other investors in the GL Pharm Tech KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ 204840 share price (ISIN: KR7204840003) to enhance your trading decisions with our free investment tools and resources.
What Is the GL Pharm Tech Corp Share Price Today?
The GL Pharm Tech share price today is 1,045.
What Is the Stock Symbol for GL Pharm Tech Corp
The stock symbol (or 'ticker') for GL Pharm Tech Corp is "204840."
What Stock Exchange Does GL Pharm Tech Corp Trade On?
GL Pharm Tech Corp is listed and trades on the KOSDAQ stock exchange.
Is GL Pharm Tech Corp a Good Stock to Buy?
Determining whether GL Pharm Tech Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
KOSDAQ
Currency in KRW
1,045
-12(-1.14%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,045
1,064
52 wk Range
1,000
1,390
204840 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,0451,064
52 wk Range
1,0001,390
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
204840 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
18/03/2026
EPS / Forecast
-- / --
Revenue / Forecast
9.53B / --
Compare 204840 to Peers and Sector
Metrics to compare | 204840 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship204840PeersSector | |
|---|---|---|---|---|
P/E Ratio | 6,488.8x | 6.5x | −0.5x | |
PEG Ratio | - | 0.11 | 0.00 | |
Price/Book | 4.1x | 0.8x | 2.6x | |
Price / LTM Sales | 2.3x | 0.7x | 3.2x | |
Upside (Analyst Target) | - | 39.1% | 50.8% | |
Fair Value Upside | Unlock | 0.6% | 7.7% | Unlock |
GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further, it provides Cabalin CR extended-release tablet and Jample Ibufen syrup for the nervous system and sensory organs; Gisoren tablets for individual organs, digestive system, and peptic ulcer drugs; and Genstring Troki for treating individual organs and digestive system, as well as oral use. GL Pharm Tech Corp. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
FAQ
What Is the GL Pharm Tech (KOSDAQ: 204840) Share Price Today?
The GL Pharm Tech stock price today is 1,045 KRW.
What Stock Exchange Does GL Pharm Tech (204840) Trade On?
GL Pharm Tech is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for GL Pharm Tech?
The stock symbol (also called a 'ticker') for GL Pharm Tech is "204840."
What Is the Current GL Pharm Tech Market Capitalisation?
As of today, GL Pharm Tech (KOSDAQ: 204840) market cap is 81.97B KRW.
Is 204840 a Buy or Sell From a Technical Analyst Perspective?
Based on today's GL Pharm Tech moving averages and other technical indicators, the daily buy/sell signal for 204840 stock is Strong Sell.
How Many Times Has GL Pharm Tech Stock Split?
GL Pharm Tech has split 1 times. (See the 204840 stock split history page for full effective split date and price information.)
How Many Employees Does GL Pharm Tech Have?
GL Pharm Tech has 33 employees, based on their latest Companies House report.
What is the current trading status of GL Pharm Tech (KOSDAQ: 204840)?
As of 30/04/2026, GL Pharm Tech (204840) is trading at a share price of 1,045 KRW, with a previous close of 1,057 KRW. The stock has fluctuated within a day range of 1,045 KRW to 1,064 KRW, while its 52-week range spans from 1,000 KRW to 1,390 KRW.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.